Simple Science

Cutting edge science explained simply

# Biology # Biochemistry

The Role of Alpha-Synuclein in Brain Health

Learn how alpha-synuclein aggregates affect brain function and disease.

Svenja Jäger, Jessica Tittelmeier, Thi Lieu Dang, Tracy Bellande, Virginie Redeker, Alexander K. Buell, Ronald Melki, Carmen Nussbaum-Krammer, Bernd Bukau, Anne S. Wentink

― 5 min read


Alpha-Synuclein: A Brain Alpha-Synuclein: A Brain Battle brain health. Discover how protein clumps challenge
Table of Contents

Alpha-synuclein is a protein that is present in the brain and is thought to play a role in the communication between nerve cells. However, when it clumps together and forms Aggregates, it is linked to several neurodegenerative diseases, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. These aggregates can disrupt normal cell functioning and are a hallmark of these diseases.

Aggregates and Their Types

In healthy brains, proteins are well-behaved, but in some conditions, alpha-synuclein starts to misbehave. It can fold incorrectly and form aggregates or clumps that are hard to break apart. These aggregates are often referred to as amyloid fibrils. They come in different varieties or polymorphs based on their structure, and each type can affect how they interact with other cells in the brain.

The Problem with Aggregates

These protein clumps aren't just messy; they can be harmful. They interfere with cellular processes, leading to cell death and the symptoms of neurodegenerative diseases. Each type of aggregation can spread differently in the brain, causing various symptoms and disease progression.

The Role of Molecular Chaperones

Enter molecular chaperones, the unsung heroes of the protein world. These are special helpers that assist in the proper folding of proteins and help dismantle misfolded or aggregated proteins. They make sure proteins behave themselves! One such chaperone is called Hsc70, which works in tandem with friends like DnaJB1 and Apg2.

How Do Chaperones Work?

When aggregates form, chaperones try to bind to them and pull apart the clumps. However, not all aggregates are created equal. Some are stubborn and resist the efforts of chaperones to break them apart. This difference in how chaperones can handle different types of aggregates is crucial when it comes to understanding the progression of diseases.

Different Polymorphs and Their Disaggregation

Research shows that different forms of alpha-synuclein aggregates can either be easily dissolved by chaperones or be really tough cookies to crack. For instance, some forms like XG and F65 were found to be easier for Hsc70 to disassemble compared to others like Ri and F110, which just laugh in the face of disaggregation attempts.

The Experiment: Testing Disaggregation

Scientists tested various alpha-synuclein aggregates with the chaperone machinery to see which could be disassembled successfully. They found that some aggregates, after being exposed to chaperones, were more readily broken down into smaller pieces, while others remained intact.

What Happens When Aggregates Break Apart?

When aggregates are broken into smaller pieces, the situation can become tricky. Just like when you break a cookie apart: you might end up with more cookie crumbs than you expected! These smaller fragments can still be pathogenic, meaning they can also cause problems and might even lead to more aggregation.

Seeding Capability of Fragments

The smaller fragments exhibit a “seeding” ability, meaning they can promote the aggregation of more alpha-synuclein proteins in a domino effect. This is similar to how a snowball can grow as it rolls downhill, gathering more snow.

Why Do Some Aggregates Break Apart More Easily?

Now, you might wonder why some aggregates get pulled apart by chaperones more easily than others. It appears that how stable or rigid the aggregate is can greatly influence whether it can be disassembled. More stable aggregates tend to hold on to their shape and resist being unraveled, while less stable ones can be more easily influenced.

The Chaperone-Polymorph Relationship

The interaction between chaperones and the aggregates is like a dance – it's all about how well they fit together. When the chaperones can recognize and bind to the aggregates easily, they can do their job much more effectively.

How Are Chaperones and Aggregates Connected in Disease?

Chaperones normally help prevent neurodegenerative diseases by managing protein aggregation. However, as the aggregates grow and change in structure, they may become less recognizable to chaperones, making it harder for them to disaggregate the proteins.

The Role of Temperature and Stability

Research has shown that temperature can affect the stability of these aggregates. When cooled down, some aggregates become more unstable and can potentially be disaggregated more easily. If chaperones are around during this cooling, they might grab hold and help break them apart.

The Bright Side: Potential for Therapy

Understanding how chaperones interact with alpha-synuclein aggregates opens the door to new therapeutic strategies. By enhancing the function of chaperones or finding ways to promote disaggregation, it may become possible to slow down or even prevent the progression of diseases associated with these protein aggregates.

The Challenge of Developing Therapies

While the potential is there, developing therapies is not as simple as it may seem. Every type of aggregate behaves differently, and in a living organism, the environment can greatly affect how proteins interact. What works in a test tube may not work in the complex world of a human brain.

Conclusion: The Ongoing Battle with Alpha-Synuclein

The research around alpha-synuclein and its interaction with chaperones is ongoing. Each discovery sheds light on the complex world of protein aggregation and provides insights into how to better tackle neurodegenerative diseases. With continued exploration, scientists hope to find ways to keep protein aggregates from wreaking havoc in the brain and, ideally, keep our brains working smoothly as we age.

While the battle between aggregates and chaperones may seem like a never-ending saga, there’s hope on the horizon. After all, even the toughest cookies can crumble with a little help!

Original Source

Title: Structural polymorphism of alpha-synuclein fibrils alters pathway of Hsc70 mediated disaggregation

Abstract: The pathological aggregation of -synuclein into amyloid fibrils is a hallmark of synucleinopathies including Parkinsons disease. Despite this commonality, synucleinopathies display divergent disease phenotypes that have been attributed to disease specific three-dimensional structures of -synuclein fibrils, each with a unique toxic gain-of-function profile. The Hsc70 chaperone is remarkable in its ability to disassemble pre-existing amyloid fibrils of different proteins in an ATP and co-chaperone dependent manner. We find however, using six well-defined conformational polymorphs of -synuclein fibrils, that the activity of the Hsc70 disaggregase machinery is sensitive to differences in the amyloid conformation, confirming that fibril polymorphism directly affects interactions with the proteostasis network. Amyloid conformation influences not only how efficiently fibrils are cleared by the Hsc70 machinery but also the preferred pathway of disaggregation. We further show that, in vitro, the active processing of fibrils by the Hsc70 machinery inadvertently produces seeding competent species that further promote protein aggregation. Amyloid conformation thus is an important feature that can tilt the balance between beneficial or detrimental protein quality control activities in the context of disease.

Authors: Svenja Jäger, Jessica Tittelmeier, Thi Lieu Dang, Tracy Bellande, Virginie Redeker, Alexander K. Buell, Ronald Melki, Carmen Nussbaum-Krammer, Bernd Bukau, Anne S. Wentink

Last Update: 2024-12-04 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.02.626355

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.02.626355.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles